Evidence map›Paper›PMID 23480249›Full record

Trial reportJournal of addictive diseases2013

A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.

Anne M Neumann, Richard D Blondell, Urmo Jaanimägi, Amanda K Giambrone, Gregory G Homish, Jacqueline R Lozano, Urszula Kowalik, Mohammadreza Azadfard

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of addictive diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01559454 (A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients), which is not on this map. Cited by 43 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 7 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01559454 phase4completednot on this map

A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients

TypeinterventionalSponsorState University of New York at BuffaloRan2012 to 2014Enrolled19ConditionsLow Back PainArmsMethadone, Buprenorphine/naloxone
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 7 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Guideline
  2. Pooled it
  3. Pooled it
  4. Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.Canadian family physician Medecin de famille canadien · 2019
    Pooled it
  5. Pooled it
  6. Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.Canadian family physician Medecin de famille canadien · 2014
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anne M NeumannPrimary Care Research Institute, Department of Family Medicine, State University of New York at Buffalo, Buffalo, New York, USA.
Richard D Blondell
Urmo Jaanimägi
Amanda K Giambrone
Gregory G Homish
Jacqueline R Lozano
Urszula Kowalik
Mohammadreza Azadfard
University at Buffalo, State University of New York · US

Funding

Medical Strategies for the Management of Pain in the Addicted PatientR03DA029768 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BLONDELL, RICHARD D · 2011 to 2012
$159k
NIDA NIH HHS R03 DA 029768NIDA NIH HHS R03 DA029768
6 · The paper itself

Abstract

Patients with opioid addiction who receive prescription opioids for treatment of nonmalignant chronic pain present a therapeutic challenge. Fifty-four participants with chronic pain and opioid addiction were randomized to receive methadone or buprenorphine/naloxone. At the 6-month follow-up examination, 26 (48.1%) participants who remained in the study noted a 12.75% reduction in pain (P = 0.043), and no participants in the methadone group compared to 5 in the buprenorphine group reported illicit opioid use (P = 0.039). Other differences between the two conditions were not found. Long-term, low-dose methadone or buprenorphine/naloxone treatment produced analgesia in participants with chronic pain and opioid addiction.

Indexed as

Substance Abuse DetectionAdministration, SublingualAnalgesics, OpioidAnalysis of VarianceBuprenorphineChronic PainDrug CombinationsFemaleHumansMaleMethadoneMiddle AgedNaloxoneOpioid-Related DisordersPrescription Drug MisuseSeverity of Illness IndexAnalgesics, OpioidBuprenorphineDrug CombinationsMethadoneNaloxone

Identifiers

PMID23480249
PMCPMC3604999
OpenAlexW1968420582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.